V030-2570 Screening compound: 1-[4-(4-methoxybenzoyl)-3-(morpholinocarbonyl)-1-oxa-4,8-diazaspiro[4.5]dec-8-yl]-3-methyl-1-butanone

V030-2570 Screening compound: 1-[4-(4-methoxybenzoyl)-3-(morpholinocarbonyl)-1-oxa-4,8-diazaspiro[4.5]dec-8-yl]-3-methyl-1-butanone
V030-2570 Screening compound: 1-[4-(4-methoxybenzoyl)-3-(morpholinocarbonyl)-1-oxa-4,8-diazaspiro[4.5]dec-8-yl]-3-methyl-1-butanone alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-2570
1-[4-(4-methoxybenzoyl)-3-(morpholinocarbonyl)-1-oxa-4,8-diazaspiro[4.5]dec-8-yl]-3-methyl-1-butanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-2570

Molecular Formula

C25H35N3O6 (C25 H35 N3 O6)

Compound Name

1-[4-(4-methoxybenzoyl)-3-(morpholinocarbonyl)-1-oxa-4,8-diazaspiro[4.5]dec-8-yl]-3-methyl-1-butanone

IUPAC name

1-[4-(4-methoxybenzoyl)-3-(morpholine-4-carbonyl)-1-oxa-48-diazaspiro[4.5]decan-8-yl]-3-methylbutan-1-one

SMILES

CC(C)CC(N(CC1)CCC11OCC(C(N2CCOCC2)=O)N1C(c(cc1)ccc1OC)=O)=O

InChI

InChI=1S/C25H35N3O6/c1-18(2)16-22(29)26-10-8-25(9-11-26)28(23(30)19-4-6-20(32-3)7-5-19)21(17-34-25)24(31)27-12-14-33-15-13-27/h4-7,18,21H,8-17H2,1-3H3/t21-/m0/s1

InChI Key

VGNKJHYLOFAYMU-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19774235

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.257

Distribution Coefficient, logD

1.257

Water Solubility, LogSw

-1.84

Polar Surface Area

71.427

Acid Dissociation Constant (pKa)

20.29

Base Dissociation Constant (pKb)

-0.06

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

64.00

V030-2570 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V030-2570 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-2570?
Check Price and Availability of V030-2570, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-2570 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-2570
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-2570
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-2570 available by request